Beta-thalassemia
Open accessThe DOI matches its Crossref record; 4 of the 89 references it cites were found in a registry or an index, and 85 are not checked yet.
Abstract
Beta-thalassemia is caused by the reduced (beta) or absent (beta) synthesis of the beta globin chains of the hemoglobin tetramer. Three clinical and hematological conditions of increasing severity are recognized, i.e., the beta-thalassemia carrier state, thalassemia intermedia, and thalassemia major. The beta-thalassemia carrier state, which results from heterozygosity for beta-thalassemia, is clinically asymptomatic and is defined by specific hematological features. Thalassemia major is a severe transfusion-dependent anemia. Thalassemia intermedia comprehend a clinically and genotypically very heterogeneous group of thalassemia-like disorders, ranging in severity from the asymptomatic carrier state to the severe transfusion-dependent type. The clinical severity of beta-thalassemia is related to the extent of imbalance between the alpha and nonalpha globin chains. The beta globin (HBB) gene maps in the short arm of chromosome 11, in a region containing also the delta globin gene, the embryonic epsilon gene, the fetal A-gamma and G-gamma genes, and a pseudogene (psiB1). Beta-thalassemias are heterogeneous at the molecular level. More than 200 disease-causing mutations have been so far identified. The majority of mutations are single nucleotide substitutions, deletions, or insertions of oligonucleotides leading to frameshift. Rarely, beta-thalassemia results from gross gene deletion. In addition to the variation of the phenotype resulting from allelic heterogeneity at the beta globin locus, the phenotype of beta-thalassemia could also be modified by the action of genetic factors mapping outside the globin gene cluster and not influencing the fetal hemoglobin. Among these factors, the ones best delineated so far are those affecting bilirubin, iron, and bone metabolisms. Because of the high carrier rate for HBB mutations in certain populations and the availability of genetic counseling and prenatal diagnosis, population screening is ongoing in several at-risk populations in the Mediterranean. Population screening associated with genetic counseling was extremely useful by allowing couples at risk to make informed decision on their reproductive choices. Clinical management of thalassemia major consists in regular long-life red blood cell transfusions and iron chelation therapy to remove iron introduced in excess with transfusions. At present, the only definitive cure is bone marrow transplantation. Therapies under investigation are the induction of fetal hemoglobin with pharmacologic compounds and stem cell gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
Anderson, L. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2822 · Cited by 1,682
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,552
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
McGuire, W., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,169
Rund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance
St. Pierre, T. G., Clark, P. R., Chua-anusorn, W., Fleming, A. J., Jeffrey, G. P., Olynyk, J. K., Pootrakul, P., Robins, E., & Lindeman, R. (2005) · Blood · doi:10.1182/blood-2004-01-0177 · Cited by 909
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854
Cappellini, M. D. (2006) · Blood · doi:10.1182/blood-2005-08-3430 · Cited by 717
Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias
Weatherall, D. J. (2001) · Nature Reviews Genetics · doi:10.1038/35066048 · Cited by 692
Uda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V. G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711566105 · Cited by 672
Self-citationA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614
Lettre, G., Sankaran, V. G., Bezerra, M. A. C., Araújo, A. S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F. F., Hirschhorn, J. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804799105 · Cited by 561
Self-citationA QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., et al. (2007) · Nature Genetics · doi:10.1038/ng2108 · Cited by 529
The hypercoagulable state in thalassemia
Eldor, A., & Rachmilewitz, E. A. (2002) · Blood · doi:10.1182/blood.v99.1.36 · Cited by 503
Pennell, D. J. (2006) · Blood · doi:10.1182/blood-2005-07-2948 · Cited by 495
Tanner, M. A., Galanello, R., Dessi, C., Smith, G. C., Westwood, M. A., Agus, A., Roughton, M., Assomull, R., Nair, S. V., Walker, J. M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.648790 · Cited by 482
Self-citationDisorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management
Somervaille, T. (2001) · Journal of the Royal Society of Medicine · doi:10.1177/014107680109401119 · Cited by 432
Anderson, L. J., Wonke, B., Prescott, E., Holden, S., Malcolm Walker, J., & Pennell, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09740-4 · Cited by 430
8 The population genetics of the haemoglobinopathies
Flint, J., Harding, R. M., Boyce, A. J., & Clegg, J. B. (1993) · Baillière's Clinical Haematology · doi:10.1016/s0950-3536(05)80071-x · Cited by 424
Anderson, L. J., Westwood, M. A., Holden, S., Davis, B., Prescott, E., Wonke, B., Porter, J. B., Malcolm Walker, J., & Pennell, D. J. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05202.x · Cited by 414
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease
Locatelli, F. (2003) · Blood · doi:10.1182/blood-2002-07-2090 · Cited by 386
Borgna-Pignatti, C. (2006) · Blood · doi:10.1182/blood-2005-07-2933 · Cited by 376
Liver iron concentrations and urinary hepcidin in -thalassemia
Origa, R., Galanello, R., Ganz, T., Giagu, N., Maccioni, L., Faa, G., & Nemeth, E. (2007) · Haematologica · doi:10.3324/haematol.10842 · Cited by 365
Self-citationSafety and effectiveness of long-term therapy with the oral iron chelator deferiprone
Cohen, A. R., Galanello, R., Piga, A., De Sanctis, V., & Tricta, F. (2003) · Blood · doi:10.1182/blood-2002-10-3280 · Cited by 323
Self-citationNeufeld, E. J. (2006) · Blood · doi:10.1182/blood-2006-02-002394 · Cited by 315
Thein, S. L., Menzel, S., Peng, X., Best, S., Jiang, J., Close, J., Silver, N., Gerovasilli, A., Ping, C., Yamaguchi, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611393104 · Cited by 314
Gardenghi, S., Marongiu, M. F., Ramos, P., Guy, E., Breda, L., Chadburn, A., Liu, Y., Amariglio, N., Rechavi, G., Rachmilewitz, E. A., et al. (2007) · Blood · doi:10.1182/blood-2006-09-048868 · Cited by 313
Cheung, M.-C., Goldberg, J. D., & Kan, Y. W. (1996) · Nature Genetics · doi:10.1038/ng1196-264 · Cited by 251
Tanner, M. A., Galanello, R., Dessi, C., Smith, G. C., Westwood, M. A., Agus, A., Pibiri, M., Nair, S. V., Walker, J. M., & Pennell, D. J. (2008) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-10-12 · Cited by 238
Self-citationRivella, S., May, C., Chadburn, A., Rivière, I., & Sadelain, M. (2003) · Blood · doi:10.1182/blood-2002-10-3305 · Cited by 220
Combined therapy with deferiprone and desferrioxamine
Wonke, Wright, & Hoffbrand (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01002.x · Cited by 218
The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients
Ceci, A., Baiardi, P., Felisi, M., Cappellini, M. D., Carnelli, V., De Sanctis, V., Galanello, R., Maggio, A., Masera, G., Piga, A., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03554.x · Cited by 215
Self-citationVoskaridou, E., & Terpos, E. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05143.x · Cited by 208
Fernandez-Reyes, D. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1357 · Cited by 203
Dhallan, R., Guo, X., Emche, S., Damewood, M., Bayliss, P., Cronin, M., Barry, J., Betz, J., Franz, K., Gold, K., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60115-9 · Cited by 202
Discovering the genetics underlying foetal haemoglobin production in adults
Thein, S. L., & Menzel, S. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07650.x · Cited by 201
Successful correction of the human β-thalassemia major phenotype using a lentiviral vector
Puthenveetil, G., Scholes, J., Carbonell, D., Qureshi, N., Xia, P., Zeng, L., Li, S., Yu, Y., Hiti, A. L., Yee, J.-K., et al. (2004) · Blood · doi:10.1182/blood-2004-04-1427 · Cited by 182
Davis, B. A., O'Sullivan, C., Jarritt, P. H., & Porter, J. B. (2004) · Blood · doi:10.1182/blood-2003-08-2841 · Cited by 180
Wanless, I. R. (2002) · Blood · doi:10.1182/blood-2002-01-0306 · Cited by 175
Hepatocellular carcinoma in the thalassaemia syndromes
Borgna‐Pignatti, C., Vergine, G., Lombardo, T., Cappellini, M. D., Cianciulli, P., Maggio, A., Renda, D., Lai, M. E., Mandas, A., Forni, G., et al. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04732.x · Cited by 174
Sedgewick, A. E., Timofeev, N., Sebastiani, P., So, J. C. C., Ma, E. S. K., Chan, L. C., Fucharoen, G., Fucharoen, S., Barbosa, C. G., Vardarajan, B. N., et al. (2008) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2008.06.007 · Cited by 172
Amelioration of Sardinian 0 thalassemia by genetic modifiers
Galanello, R., Sanna, S., Perseu, L., Sollaino, M. C., Satta, S., Lai, M. E., Barella, S., Uda, M., Usala, G., Abecasis, G. R., et al. (2009) · Blood · doi:10.1182/blood-2009-04-217901 · Cited by 164
Self-citationdel Giudice, E. M., Perrotta, S., Nobili, B., Specchia, C., d’Urzo, G., & Iolascon, A. (1999) · Blood · doi:10.1182/blood.v94.7.2259.419k42_2259_2262 · Cited by 159
Loss of α-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia
Kong, Y., Zhou, S., Kihm, A. J., Katein, A. M., Yu, X., Gell, D. A., Mackay, J. P., Adachi, K., Foster-Brown, L., Louden, C. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21982 · Cited by 158
Freson, K., Matthijs, G., Thys, C., Mariën, P., Hoylaerts, M. F., Vermylen, J., & Geet, C. V. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.2.147 · Cited by 146
Cao, A., Rosatelli, M. C., Monni, G., & Galanello, R. (2002) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(01)00006-7 · Cited by 146
Self-citationNasa, G. L., Argiolu, F., Giardini, C., Pession, A., Fagioli, F., Caocci, G., Vacca, A., Stefano, P. D., Piras, E., Ledda, A., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.023 · Cited by 144
Beta‐thalassaemia intermedia: is it possible consistently to predict phenotype from genotype?
Ho, Hall, ., Luo, Weatherall, & Thein (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00519.x · Cited by 142
Modern treatment of thalassaemia intermedia
Borgna‐Pignatti, C. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06654.x · Cited by 124
Westwood, M. A., Firmin, D. N., Gildo, M., Galanello, R., Gotsis, S. D., Karagiorga, M., Vasili, B., & Pennell, D. J. (2005) · International journal of cardiac imaging · doi:10.1007/s10554-005-0651-2 · Cited by 122
Self-citationViprakasit, V. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.24.2797 · Cited by 121
Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia
Bradai, M., Abad, M. T., Pissard, S., Lamraoui, F., Skopinski, L., & de Montalembert, M. (2003) · Blood · doi:10.1182/blood-2003-01-0117 · Cited by 116
Wahlberg, K. E., Jiang, J., Rooks, H., Jawaid, K., Matsuda, F., Yamaguchi, M., Lathrop, M. G., Thein, S. L., & Best, S. (2009) · Blood · doi:10.1182/blood-2009-03-210146 · Cited by 107
BONE DISEASE IN β‐THALASSAEMIA MAJOR
Wonke (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01107.x · Cited by 98
DOMINANT β THALASSAEMIA: MOLECULAR BASIS AND PATHOPHYSIOLOGY
Thein, S. L. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb08132.x · Cited by 95
Genotype-phenotype correlations in β-thalassemias
Cao, A., Galanello, R., & Rosatelli, M. C. (1994) · Blood Reviews · doi:10.1016/0268-960x(94)90002-7 · Cited by 89
Self-citationMolecular therapies in β‐thalassaemia
Quek, L., & Thein, S. L. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06408.x · Cited by 88
Weizer‐Stern, O., Adamsky, K., Amariglio, N., Levin, C., Koren, A., Breuer, W., Rachmilewitz, E., Breda, L., Rivella, S., Ioav Cabantchik, Z., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06258.x · Cited by 80
Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background
Perrotta, S., Cappellini, M. D., Bertoldo, F., Servedio, V., Iolascon, G., D’Agruma, L., Gasparini, P., Siciliani, M. C., & Iolascon, A. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02382.x · Cited by 80
Garner, C. P., Tatu, T., Best, S., Creary, L. E., & Thein, S. L. (2002) · The American Journal of Human Genetics · doi:10.1086/339248 · Cited by 78
Vrettou, C., Traeger‐Synodinos, J., Tzetis, M., Malamis, G., & Kanavakis, E. (2003) · Clinical Chemistry · doi:10.1373/49.5.769 · Cited by 77
Cappellini, M. D., Tavazzi, D., Duca, L., Graziadei, G., Mannu, F., Turrini, F., Arese, P., & Fiorelli, G. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01217.x · Cited by 77
Light and shadows in the iron chelation treatment of haematological diseases
Maggio, A. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06666.x · Cited by 77
Stem cell transplantation for hemoglobinopathies
Gaziev, J., & Lucarelli, G. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200302000-00005 · Cited by 73
Lai, M. I., Jiang, J., Silver, N., Best, S., Menzel, S., Mijović, A., Colella, S., Ragoussis, J., Garner, C. P., Weiss, M. J., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06075.x · Cited by 71
Hyperbilirubinaemia in heterozygous β‐thalassaemia is related to co‐inherited Gilbert's syndrome
Galanello, R., Perseu, L., Melis, M., Cipollina, L., Barella, S., Giagu, N., Turco, M., Maccioni, O., & Cao, A. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.3703182.x · Cited by 71
Self-citationMaggio, A., Vitrano, A., Capra, M., Cuccia, L., Gagliardotto, F., Filosa, A., Romeo, M. A., Magnano, C., Caruso, V., Argento, C., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07609.x · Cited by 71
BCL11A represses HBG transcription in K562 cells
Chen, Z., Luo, H., Steinberg, M. H., & Chui, D. H. K. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2008.12.003 · Cited by 66
IS IT DOMINANTLY INHERITED β THALASSAEMIA OR JUST A β‐CHAIN VARIANT THAT IS HIGHLY UNSTABLE?
Thein, S. L. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01492.x · Cited by 65
Pace, B. S., & Zein, S. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20802 · Cited by 65
Quantitative trait locus on chromosome 8q influences the switch from fetal to adult hemoglobin
Garner, C. P., Silver, N., Best, S., Menzel, S., Martin, C., Spector, T. D., & Thein, S. L. (2004) · Blood · doi:10.1182/blood-2004-02-0527 · Cited by 62
Mavrou, A., Kouvidi, E., Antsaklis, A. J., Souka, A. P., Tzeli, S. K., & Kolialexi, A. (2006) · Prenatal Diagnosis · doi:10.1002/pd.1640 · Cited by 53
Therapeutic Options for Patients with Severe β-Thalassemia: The Need for Globin Gene Therapy
Sadelain, M., Boulad, F., Galanello, R., Giardina, P. J., Locatelli, F., Maggio, A., Rivella, S., Rivière, I., & Tisdale, J. F. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.151 · Cited by 51
Self-citationCorrection of the sickle cell mutation in embryonic stem cells
Chang, J. C., Ye, L., & Kan, Y. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510177103 · Cited by 49
The triplicated α gene locus and β thalassaemia
Kanavakis, E., Metaxotou-Mavromati, A., Kattamis, C., et al. (1983) · British Journal of Haematology · doi:10.1111/j.1365-2141.1983.tb02088.x · Cited by 48
Multiple Mutations Produce δβ 0 Thalassemia in Sardinia
Pirastu, M., Kan, Y. W., Galanello, R., & Cao, A. (1984) · Science · doi:10.1126/science.6198720 · Cited by 47
Self-citationA novel mechanism for thalassaemia intermedia
Badens, C., Mattéi, M., Imbert, A., Lapouméroulie, C., Martini, N., Michel, G., & Lena‐Russo, D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07338-5 · Cited by 45
The Role of Genomics in Studying Genetic Susceptibility to Infectious Disease: Figure 1.Preprint
Weatherall, D. J., Clegg, J. B., & Kwiatkowski, D. P. (1997) · Genome Research · doi:10.1101/gr.7.10.967 · Cited by 43
Tamagnini, G. P., Lopes, M. C., Castanheira, M., et al. (1983) · British Journal of Haematology · doi:10.1111/j.1365-2141.1983.tb02087.x · Cited by 43
Galanello, R., Perseu, L., Perra, C., Maccioni, L., Barella, S., Longinotti, M., Cao, A., & Cazzola, M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05237.x · Cited by 30
Self-citationWainscoat, J. S., Thein, S. L., & Weatherall, D. J. (1987) · Blood Reviews · doi:10.1016/0268-960x(87)90029-4 · Cited by 28
Nontransfusional Iron Overload in Thalassemia: Association with Hereditary Hemochromatosis
Rees, D. C., Singh, B. M., Luo, L., Wickramasinghe, S. N., & Thein, S. L. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10530.x · Cited by 21
The Interaction of Anti 3. 7 Type Quadruplicated α-Globin Genes and Heterozygous β-Thalassemia
Thompson, C. C., Ali, M., Vacovsky, M., & Boyadjian, S. (1989) · Hemoglobin · doi:10.3109/03630268908998062 · Cited by 15
Molecular pathology of thalassemia intermedia
Cao, A., Gasperini, D., Podda, A. S., & Galanello, R. (1990) · European Journal of Internal Medicine · Cited by 12
Self-citation
Research works printed but not linked: 5
- Wheatherall DJ, Clegg JB. The thalassemia syndromes. 4th ed. Oxford, England: Blackwell Science Ltd, 2001.
- Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In: Scriver CR, Beaudet Al, Sly WS, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease (OMMBID). Chapter 101. New York, NY: McGraw-Hill, 2002. Available at: www.ommbid.com. Accessed December 31, 2007.
- Rees, 1998, Genetic influenes on bone disease in thalassemia, Blood, 92, S532a
- Dresner Pollak, 2000, Bone mineral metabolism in adults with beta thalassemia major and intermedia, Br J Haematol, 111, 902
- Galanello, 1990, Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosome, Blood, 15, 75:11747
Cited by
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y.-S., Domm, J., Eustace, B. K., Foell, J., de la Fuente, J., Grupp, S., Handgretinger, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031054 · Cited by 1,962
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
Liang, P., Xu, Y., Zhang, X., Ding, C., Huang, R., Zhang, Z., Lv, J., Xie, X., Chen, Y., Li, Y., et al. (2015) · Protein & Cell · doi:10.1007/s13238-015-0153-5 · Cited by 1,135
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
Thompson, A. A., Walters, M. C., Kwiatkowski, J., Rasko, J. E. J., Ribeil, J.-A., Hongeng, S., Magrin, E., Schiller, G. J., Payen, E., Semeraro, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705342 · Cited by 684
Cornerstones of CRISPR–Cas in drug discovery and therapy
Fellmann, C., Gowen, B. G., Lin, P.-C., Doudna, J. A., & Corn, J. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.238 · Cited by 443
Metadata
- Authors
- Cao, A., & Galanello, R.
- Affiliations
- National Research Council (IT)
- University of Cagliari (IT)
- Corresponding author
- Cao, Antonio
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 12
- Issue
- 2
- Pages
- 61-76
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W4210970197
- Cited by
- 722
- References
- 4
- Citations by year
- 2026: 43 · 2025: 48 · 2024: 63 · 2023: 61 · 2022: 60 · 2021: 66 · 2020: 69 · 2019: 64 · 2018: 48 · 2017: 58 · 2016: 52 · 2015: 24 · 2014: 14 · 2013: 20 · 2012: 15
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4370 d)
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- beta-thalassemia, beta-globin gene, HBB mutations, thalassemia major, thalassemia intermedia, transfusion-dependent anemia, iron chelation therapy, bone marrow transplantation, fetal hemoglobin induction, genetic counseling, prenatal diagnosis, chromosome 11
- MeSH terms
- Female, Multigene Family, Genetic Testing, Globins, Genetic Carrier Screening, Humans, Pregnancy, Prenatal Diagnosis, Bone Marrow Transplantation, beta-Thalassemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.